Invention Application
- Patent Title: NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS
-
Application No.: US17794641Application Date: 2021-01-22
-
Publication No.: US20230128198A1Publication Date: 2023-04-27
- Inventor: Dai CHENG , Mingming CHEN , Amin LI , Haijun LI , Guiqun YANG
- Applicant: JACOBIO PHARMACEUTICALS CO., LTD.
- Applicant Address: CN Beijing
- Assignee: JACOBIO PHARMACEUTICALS CO., LTD.
- Current Assignee: JACOBIO PHARMACEUTICALS CO., LTD.
- Current Assignee Address: CN Beijing
- Priority: CNPCT/CN2020/073786 20200122,CNPCT/CN2020/076159 20200221,CNPCT/CN2020/085922 20200421
- International Application: PCT/CN2021/073169 WO 20210122
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D417/14 ; C07D405/14 ; C07D413/14 ; C07D409/14 ; C07D401/12
Abstract:
Provided are compounds of formula (I), or pharmaceutically acceptable salts thereof, which can be used for inhibiting the activity of Aurora A and treating cancer mediated by Aurora A.
Information query
